Retrieve available abstracts of 21 articles: HTML format
Single Articles
June 2025
NAITOH I, Isayama H, Akamatsu N, Mizuno S, et al The 2024 diagnostic criteria for primary sclerosing cholangitis.
J Gastroenterol. 2025 Jun 12. doi: 10.1007/s00535-025-02265. PubMedAbstract available
May 2025
ZHU J, Chen H, Meng L, Jiang J, et al Serum FGF19 combined with GGT and other biomarkers predicted native liver
survival following Kasai portoenterostomy in early biliary atresia.
J Gastroenterol. 2025 May 5. doi: 10.1007/s00535-025-02234. PubMedAbstract available
April 2025
YOSHIDA M, Toyohara T, Hori Y, Kato A, et al Endoscopic liquid biopsy of bile: superior diagnostic and prognostic performance
of bile-derived exosomal miR-21-5p for biliary tract cancers.
J Gastroenterol. 2025 Apr 23. doi: 10.1007/s00535-025-02250. PubMedAbstract available
February 2025
HAO Z, Lu Y, Hao Y, Luo Y, et al Correction: Fungal mycobiome dysbiosis in choledocholithiasis concurrent with
cholangitis.
J Gastroenterol. 2025 Feb 27. doi: 10.1007/s00535-025-02217. PubMed
TANAKA A, Notohara K, Tobari M, Abe M, et al A clinicopathological study of IgG4-related autoimmune hepatitis and
IgG4-hepatopathy.
J Gastroenterol. 2025 Feb 8. doi: 10.1007/s00535-025-02221. PubMedAbstract available
November 2024
HAO Z, Lu Y, Hao Y, Luo Y, et al Fungal mycobiome dysbiosis in choledocholithiasis concurrent with cholangitis.
J Gastroenterol. 2024 Nov 27. doi: 10.1007/s00535-024-02183. PubMedAbstract available
YASUDA M, Shiokawa M, Kuwada T, Nishikawa Y, et al Anti-integrin alphavbeta6 autoantibody in primary sclerosing cholangitis: a Japanese
nationwide study.
J Gastroenterol. 2024 Nov 16. doi: 10.1007/s00535-024-02169. PubMedAbstract available
CAO Z, Yang Y, Liu S, Sun L, et al FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic
cholangiocarcinoma.
J Gastroenterol. 2024 Nov 13. doi: 10.1007/s00535-024-02175. PubMedAbstract available
August 2024
TAKAOKA S, Hamada T, Nakai Y, Yasunaga H, et al Response to the letter by Buldukoglu et al. regarding our manuscript "Body mass
index and survival among patients with advanced biliary tract cancer: a
single-institutional study with nationwide data-based validation".
J Gastroenterol. 2024 Aug 6. doi: 10.1007/s00535-024-02143. PubMed
July 2024
AMPUERO J, Aller R, Gallego-Duran R, Crespo J, et al The biochemical pattern defines MASLD phenotypes linked to distinct histology and
prognosis.
J Gastroenterol. 2024;59:586-597. PubMedAbstract available
June 2024
TAKAOKA S, Hamada T, Takahara N, Fukuda R, et al Body mass index and survival among patients with advanced biliary tract cancer: a
single-institutional study with nationwide data-based validation.
J Gastroenterol. 2024 Jun 19. doi: 10.1007/s00535-024-02124. PubMedAbstract available
May 2024
KANO Y, Ishikawa T, Yamao K, Mizutani Y, et al What is the appropriate method of pathological specimen collection for
cholangiocarcinoma detection in primary sclerosing cholangitis?
J Gastroenterol. 2024 May 7. doi: 10.1007/s00535-024-02105. PubMedAbstract available
March 2024
XIN HY, Zou JX, Sun RQ, Hu ZQ, et al Characterization of tumor microbiome and associations with prognosis in
intrahepatic cholangiocarcinoma.
J Gastroenterol. 2024 Mar 10. doi: 10.1007/s00535-024-02090. PubMedAbstract available
October 2023
WU JF, Peng SS, Tai CS, Lin WH, et al The magnetic resonance imaging and age-adjusted matrix metalloproteinase-7 assist
the diagnosis of biliary atresia.
J Gastroenterol. 2023 Oct 30. doi: 10.1007/s00535-023-02051. PubMedAbstract available
WANG H, Li Y, Pu X, Liang X, et al MGAT5/TMEM163 variant is associated with prognosis in ursodeoxycholic
acid-treated patients with primary biliary cholangitis.
J Gastroenterol. 2023 Oct 16. doi: 10.1007/s00535-023-02045. PubMedAbstract available
September 2023
OZONO Y, Kawakami H, Uchiyama N, Hatada H, et al Current status and issues in genomic analysis using EUS-FNA/FNB specimens in
hepatobiliary-pancreatic cancers.
J Gastroenterol. 2023 Sep 12. doi: 10.1007/s00535-023-02037. PubMedAbstract available
July 2023
FUJITA N, Yasuda I, Endo I, Isayama H, et al Evidence-based clinical practice guidelines for cholelithiasis 2021.
J Gastroenterol. 2023 Jul 15. doi: 10.1007/s00535-023-02014. PubMedAbstract available
PENG M, Li H, Cao H, Huang Y, et al Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent
lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma.
J Gastroenterol. 2023 Jul 11. doi: 10.1007/s00535-023-02012. PubMedAbstract available
June 2023
XU H, Lin X, Li Z, He X, et al VIRMA facilitates intrahepatic cholangiocarcinoma progression through epigenetic
augmentation of TMED2 and PARD3B mRNA stabilization.
J Gastroenterol. 2023 Jun 30. doi: 10.1007/s00535-023-02015. PubMedAbstract available
YOSHIDA H, Shiokawa M, Kuwada T, Muramoto Y, et al Anti-integrin alphavbeta6 autoantibodies in patients with primary sclerosing
cholangitis.
J Gastroenterol. 2023 Jun 13. doi: 10.1007/s00535-023-02006. PubMedAbstract available
May 2023
KIM KA, Choi HY, Ki M, Jang ES, et al Epidemiological trends and outcomes of primary biliary cholangitis in South Korea
between 2009 and 2019.
J Gastroenterol. 2023 May 17. doi: 10.1007/s00535-023-01999. PubMedAbstract available